Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis

International Journal of Cardiology

Volumn 167, Issue 5, 2013, Pages 2140-2148

  Aradi, Dániel ^a   Komócsi, András ^a   Price, Matthew J ^b   Cuisset, Thomas ^c   Ari, Hasan ^d   Hazarbasanov, Dobri ^e   Trenk, Dietmar ^f   Sibbing, Dirk ^g   Valgimigli, Marco ^h   Bonello, Laurent ⁱ  

^a UNIVERSITY OF PÉCS   (Hungary)

^b SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^c TIMONE HOSPITAL   (France)

^d Bursa Postgraduate Hospital   (Turkey)

^e UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^f UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h UNIVERSITY OF FERRARA   (Italy)

ⁱ HÔPITAL NORD   (France)

Author keywords

Bleeding; Clinical outcome; Clopidogrel; High platelet reactivity; Platelet function testing

Indexed keywords

ABCIXIMAB; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; PRASUGREL; TIROFIBAN;

ACUTE CORONARY SYNDROME; ARTICLE; BLEEDING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; HEART DEATH; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; META ANALYSIS; MULTICENTER STUDY (TOPIC); NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PRIORITY JOURNAL; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; STENT THROMBOSIS; SYSTEMATIC REVIEW; THROMBOCYTE FUNCTION ANALYZER; TREATMENT OUTCOME;

BLEEDING; CLINICAL OUTCOME; CLOPIDOGREL; HIGH PLATELET REACTIVITY; PLATELET FUNCTION TESTING;

HUMANS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOSIS; TREATMENT OUTCOME;

EID: 84883281361     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.05.100     Document Type: Article

References (26)

1. S.R. Steinhubl, P.B. Berger, and J.T. Mann III Clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 19 2002 2411 2420
2. S.R. Mehta, S. Yusuf, and R.J. Peters Clopidogrel in unstable angina to prevent recurrent events trial (CURE) investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 9281 2001 527 533
3. V.L. Serebruany, S.R. Steinhubl, and P.B. Berger Variability in platelet responsiveness to clopidogrel among 544 individuals J Am Coll Cardiol 45 2 2005 246 251
4. D. Aradi, and A. Komócsi Platelet function monitoring in patients on clopidogrel: what should we learn from GRAVITAS? Platelets 23 3 2012 167 176
5. L. Bonello, U.S. Tantry, and R. Marcucci Working group on high on-treatment platelet reactivity. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 12 2010 919 933
6. S.S. Brar, J. ten Berg, and R. Marcucci Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention a collaborative meta-analysis of individual participant data J Am Coll Cardiol 58 19 2011 1945 1954
7. D. Aradi, A. Komócsi, and A. Vorobcsuk Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis Am Heart J 160 3 2010 543 551
8. G.W. Stone ADAPT-DES: a large-scale, prospective, multicenter registry examining the relationship of platelet responsiveness to stent thrombosis after DES implantation Transcatheter cardiovascular therapeutics 2011, San Francisco November 9 2011
9. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 20 2007 2001 2015
10. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 11 2009 1045 1057
11. L. Bonello, L. Camoin-Jau, and S. Arques Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study J Am Coll Cardiol 51 14 2008 1404 1411
12. L. Bonello, L. Camoin-Jau, and S. Armero Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis Am J Cardiol 103 1 2009 5 10
13. M. Valgimigli, G. Campo, and N. de Cesare Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R) investigators. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study Circulation 119 25 2009 3215 3222
14. T. Cuisset, C. Frere, and J. Quilici Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study JACC Cardiovasc Interv 1 6 2008 649 653
15. M.J. Price, P.B. Berger, and P.S. Teirstein Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA 305 11 2011 1097 1105
16. X.D. Wang, D.F. Zhang, S.W. Zhuang, and Y. Lai Modifying clopidogrel maintenance doses according to vasodilator-stimulated phosphoprotein phosphorylation index improves clinical outcome in patients with clopidogrel resistance Clin Cardiol 34 5 2011 332 338
17. D. Aradi, O. Rideg, and A. Vorobcsuk Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity Eur J Clin Invest 42 4 2012 384 392
18. H. Ari, H. Ozkan, and A. Karacinar The effect of high-dose clopidogrel treatment in patients with clopidogrel resistance (the EFFICIENT trial) Int J Cardiol 157 3 2012 374 380
19. D. Hazarbasanov, V. Velchev, and B. Finkov Tailoring clopidogrel dose according to multiple electrode aggregometry decreases the rate of ischemic complications after percutaneous coronary intervention J Thromb Thrombolysis 34 1 2012 Jul 85 90
20. D. Trenk, G.W. Stone, and M. Gawaz A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents: Results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) Study J Am Coll Cardiol 59 24 2012 2159 2164
21. M. Barza, T.A. Trikalinos, and J. Lau Statistical considerations in meta-analysis Infect Dis Clin North Am 23 2009 195 210
22. C.W. Hamm, J.P. Bassand, and S. Agewall ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 32 23 2011 2999 3054
23. G.N. Levine, E.R. Bates, and J.C. Blankenship 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention J Am Coll Cardiol 58 24 2011 2550 2583
24. CURRENT-OASIS 7 Investigators, S.R. Mehta, and J.P. Bassand Dose comparisons of clopidogrel and aspirin in acute coronary syndromes N Engl J Med 363 10 2010 930 942
25. P.G. Steg, K. Huber, and F. Andreotti Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology Eur Heart J 32 15 2011 1854 1864
26. S. Silber A new and rapid scoring system to assess the scientific evidence from clinical trials J Interv Cardiol 19 2006 485 492